The Impact of IDH1 Mutation and MGMT Promoter Methylation on Recurrence-Free Interval in Glioblastoma Patients Treated With Radiotherapy and Chemotherapeutic Agents. Kurdi, M., Butt, N., S., Baeesa, S., Alghamdi, B., Maghrabi, Y., Bardeesi, A., Saeedi, R., Al-Sinani, T., Alghanmi, N., Bari, M., O., & others Pathology and Oncology Research, Frontiers Media SA, 2021.
bibtex   
@article{
 title = {The Impact of IDH1 Mutation and MGMT Promoter Methylation on Recurrence-Free Interval in Glioblastoma Patients Treated With Radiotherapy and Chemotherapeutic Agents},
 type = {article},
 year = {2021},
 volume = {27},
 publisher = {Frontiers Media SA},
 id = {675553fc-bb4f-3cfb-b55f-d6062c7cd7ec},
 created = {2022-01-02T16:36:32.878Z},
 file_attached = {false},
 profile_id = {49efd9d1-b84a-3562-b8db-36e64ac7ba81},
 last_modified = {2022-02-11T11:41:45.634Z},
 read = {false},
 starred = {false},
 authored = {true},
 confirmed = {true},
 hidden = {false},
 citation_key = {kurdi2021impact},
 source_type = {article},
 folder_uuids = {6fdaeed4-e99e-439a-bbea-44c55d8166f2},
 private_publication = {false},
 bibtype = {article},
 author = {Kurdi, Maher and Butt, Nadeem Shafique and Baeesa, Saleh and Alghamdi, Badrah and Maghrabi, Yazid and Bardeesi, Anas and Saeedi, Rothaina and Al-Sinani, Taghreed and Alghanmi, Najla and Bari, Mohammed O and others, undefined},
 journal = {Pathology and Oncology Research}
}

Downloads: 0